Highlights in Early Breast Cancer From ESMO 2023 Highlights in Early Breast Cancer From ESMO 2023

Highlights in early breast cancer from ESMO 2023 include 5-year results from KEYNOTE-522 in TNBC, pCR benefits in ER+/HER2-, and a genomic risk score in HER2+, as reported by Dr Lisa Carey.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news